Assistant Cell Image Analyzer for Hematology Labs Released
|
By LabMedica International staff writers Posted on 19 Jul 2012 |

Image: Medica's EasyCell Assistant. Inset shows white cell surrounded by red blood cells (Photo courtesy of Medica).
AACC 2012: A cell image analyzer for hematology laboratories automates and simplifies the cell differential process by locating and preclassifying white blood cells.
Called EasyCell and manufactured by Medica Corporation (Bedford, MA, USA), the analyzer employs optical pattern recognition software to automatically locate white cells on a blood smear. It digitally stores their images, preclassifies, and then presents them for review—grouped by cell type—on a liquid crystal display (LCD) display.
The analyzer also presents images of red cells and platelets, enabling red cell morphology and platelet estimates. With its 30-position carousel, the EasyCell offers walkaway operation and a stat slide port permits immediate testing without disrupting a sample run.
EasyCell reduces sample review times by 50% over the manual differentiation process using microscopes, while helping the technologist achieve improved efficiency, accuracy, and precision.
Doug Moe, vice president of business development, Medica Corporation, said, “The EasyCell assistant lowers cost by substantially cutting the time technologists require to perform manual blood cell differentials and correctly classify normal cells."
A clinical evaluation at the Children’s Hospital Boston (Boston, MA, USA) confirmed the EasyCell efficacy in the hematology laboratory environment.
In an announcement at the 2012 Annual Meeting of the American Association for Clinical Chemistry (AACC) Expo being held July 15-19, 2012 in Los Angeles (CA, USA), the company said it is now accepting orders for the EasyCell solution and will have instruments available for global shipment during the third quarter of 2012.
Related Links:
Medica Corporation
Children’s Hospital Boston
Called EasyCell and manufactured by Medica Corporation (Bedford, MA, USA), the analyzer employs optical pattern recognition software to automatically locate white cells on a blood smear. It digitally stores their images, preclassifies, and then presents them for review—grouped by cell type—on a liquid crystal display (LCD) display.
The analyzer also presents images of red cells and platelets, enabling red cell morphology and platelet estimates. With its 30-position carousel, the EasyCell offers walkaway operation and a stat slide port permits immediate testing without disrupting a sample run.
EasyCell reduces sample review times by 50% over the manual differentiation process using microscopes, while helping the technologist achieve improved efficiency, accuracy, and precision.
Doug Moe, vice president of business development, Medica Corporation, said, “The EasyCell assistant lowers cost by substantially cutting the time technologists require to perform manual blood cell differentials and correctly classify normal cells."
A clinical evaluation at the Children’s Hospital Boston (Boston, MA, USA) confirmed the EasyCell efficacy in the hematology laboratory environment.
In an announcement at the 2012 Annual Meeting of the American Association for Clinical Chemistry (AACC) Expo being held July 15-19, 2012 in Los Angeles (CA, USA), the company said it is now accepting orders for the EasyCell solution and will have instruments available for global shipment during the third quarter of 2012.
Related Links:
Medica Corporation
Children’s Hospital Boston
Latest 2012 AACC News
- South Korea to Educate Patients About Lab Tests
- Laboratory Testing Platform for Vitamin D Assay Validated
- Nine Researchers Honored for Outstanding Achievements at AACC Meeting
- Mobile Blood Gas Analyzer for Hospital POC Launched
- Next Generation Automation Solution Exhibited at AACC
- Extended Range HRP Microwell Substrate Launched
- Automated, Compact, Random Access Chemistry Analyzer Featured at AACC
- IVD Market Exceeded USD 50 Billion in 2011
- Hematology Analyzers Offer Channel for Immature Platelet Fraction
- New Solutions for Health Labs Featured at Expo
- Blood Test Detects Patients at Risk for Diabetes
- Efficiency and Workflow Enhanced in Today’s Laboratories
- Web-Based Software Platform Manages Lab Information
Channels
Clinical Chemistry
view channel
Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features
Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more
Plasma Vitamin C Levels Associated with Brain Structure and Connectivity in Aging
Previous studies have linked vitamin C–rich diets with lower risk of cognitive impairment in older adults. However, few investigations have directly examined blood plasma vitamin C in relation to brain... Read more
Mass Spectrometry Detects Tumor Metabolites for Cancer Monitoring
Cancer’s altered metabolism complicates how clinicians detect and monitor tumors, because nutrient use can shift with context and time. Measuring small-molecule metabolites that distinguish malignant from... Read more
Urinary Biomarker Assay Predicts Kidney Disease Progression Beyond Standard Measures
Many patients with type 2 diabetes and chronic kidney disease continue to experience progressive renal decline, yet conventional markers such as albuminuria and estimated glomerular filtration rate (eGFR)... Read moreMolecular Diagnostics
view channel
Ultrasensitive HPV Blood Test Predicts Early Recurrence in Head and Neck Cancer
Human papillomavirus (HPV)-associated head and neck cancers are frequently treated with surgery, but some patients experience recurrence due to residual microscopic disease. Postoperative decisions about... Read more
New Library Normalization and Amplification Tools Support Oncology Sequencing
High-throughput next-generation sequencing (NGS) laboratories continue to grapple with uneven library pooling and amplification artifacts that can degrade variant calling accuracy and increase reruns.... Read moreHematology
view channel
Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read more
Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
Immune checkpoint inhibitors have improved outcomes across many cancers, yet only a subset of patients derive durable benefit and biomarkers to guide treatment remain limited. Eosinophils, best known for... Read moreImmunology
view channelAptamer-Based Biosensor Enables Mutation-Resilient SARS-CoV-2 Detection
Rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can undermine existing molecular diagnostics, especially when assays target small viral components. Double-antibody sandwich... Read more
Study Points to Autoimmune Pathway Behind Long COVID Symptoms
Long COVID leaves many SARS-CoV-2 survivors with persistent fatigue, cognitive issues, palpitations, and musculoskeletal pain for months or years. Estimates cited in new research suggest 4%–20% of infected... Read more
Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response
Tuberculosis (TB) remains the world’s leading infectious killer, with 10.8 million cases and 1.25 million deaths recorded globally in 2023. Yet many infected individuals never develop active disease, underscoring... Read moreMicrobiology
view channel
TORCH Infection Trends Point to Need for Tailored Screening in Pregnancy
Congenital TORCH infections can be asymptomatic during pregnancy yet cause stillbirth, birth defects, and lifelong disability in infants. Many regions still lack robust surveillance to guide testing and... Read more
New Culture Medium Speeds C. difficile Resistance Detection and Reduces Costs
Clostridioides difficile infections remain a persistent threat in hospitals and communities, affecting about 500,000 people in the United States each year. Severe cases can be fatal within 30 days of diagnosis,... Read morePathology
view channel
Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer
Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
AI Tool Speeds Brain Tumor Classification from Routine Histology Slides
Accurate classification of brain and spinal cord tumors increasingly depends on molecular profiling alongside histology, but access to such testing remains limited and results can take about two weeks.... Read more
IHC Companion Diagnostic Standardizes Mismatch Repair Testing for Cancer Immunotherapy
Deficient DNA mismatch repair is an established predictive biomarker for response to immune checkpoint inhibitors, yet access to standardized assessment has varied across tumor types. Cancer remains the... Read moreTechnology
view channel
AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
Oncology teams must manage growing volumes of genomic data, rapidly evolving clinical trial options, and frequently updated care guidelines, all within tight clinic schedules. Translating complex tumor... Read more
Agentic AI Platform Supports Genomic Decision-Making in Oncology
Oncology care teams increasingly face the challenge of managing complex molecular diagnostics, evolving treatment options, and extensive electronic health record documentation. Translating multimodal data... Read moreIndustry
view channel
Open-Source Consortium Aims to Standardize Digital Pathology Workflows
Digital pathology is expanding rapidly as laboratories adopt whole-slide imaging and computational tools to meet growing diagnostic and biomarker-testing demand. However, fragmented software infrastructure... Read more









